Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population

2012
Authors
Tadić, Ivana
Vujasinović-Stupar, Nada

Tasić, Ljiljana

Stevanović, Dejan

Dimić, Aleksandar
Stamenković, Bojana
Stojanović, Sonja
Milenković, Sasa
Article (Published version)
Metadata
Show full item recordAbstract
Background: Vertebral fractures could lead to reduced physical, social and mental functioning, and loss of personal independence. Therefore, during the treatment of osteoporosis, it has become necessary to examine the changes in everyday functioning, well-being and health related quality of life (HRQOL). To that effect, this study aims to translate, culturally adapt, and validate the Serbian version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) for patients with vertebral fractures. Methods: Nine female patients with osteoporosis participated in the pre-validation study. A validation, case-control study included two groups of female patients: one that consisted of 50 female patients with osteoporosis, and with at least one vertebral fracture, and another one that consisted of 50 control patients with osteoporosis but without fractures. They completed the QUALEFFO-41 and the EuroQol group questionnaire with five dimensions (EQ-5D) twice withi...n a month. The validation study examined internal consistency, concurrent validity, test-retest reliability, sensitivity and specificity. Results: During the pre-validation study, three of the items in the QUALEFFO-41 were slightly changed. Afterwards, during the validation study, the statistically significant differences (adjusted for: age, duration of menopause, current employment and marital status) in the mean values of all domains and total scores between the groups were noted. For the case group, the internal consistency of the QUALEFFO-41 domains and of total questionnaire was above 0.70. The test-retest reliability was tested by the intraclass correlation coefficients (ICC) that were in range 0.87 - 0.96 for the case, and 0.15 - 0.83 for the control group. Correlations between the total scores of the QUALEFFO-41 and the EQ-5D health state value, for both groups were negative and statistically significant (r = -0.78, p lt 0.001 and r = -0.73, p lt 0.001, respectively). The QUALEFFO-41 had a better prediction of the value of HRQOL of cases compared to the generic questionnaire EQ-5D (the AUC difference was 0.099, p = 0.013). Conclusions: The Serbian QUALEFFO-41 version is reliable, valid, sensitive and predictive for examinations of HRQOL in patients with prevalent vertebral fractures and can be used in further studies.
Keywords:
Osteoporosis / Validation / Quality of lifeSource:
Health and Quality of Life Outcomes, 2012, 10Publisher:
- Biomed Central Ltd, London
Funding / projects:
- Merck Sharp and Dohme, representative office in Serbia
DOI: 10.1186/1477-7525-10-74
ISSN: 1477-7525
PubMed: 22709379
WoS: 000308024700001
Scopus: 2-s2.0-84862253278
Collections
Institution/Community
PharmacyTY - JOUR AU - Tadić, Ivana AU - Vujasinović-Stupar, Nada AU - Tasić, Ljiljana AU - Stevanović, Dejan AU - Dimić, Aleksandar AU - Stamenković, Bojana AU - Stojanović, Sonja AU - Milenković, Sasa PY - 2012 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1622 AB - Background: Vertebral fractures could lead to reduced physical, social and mental functioning, and loss of personal independence. Therefore, during the treatment of osteoporosis, it has become necessary to examine the changes in everyday functioning, well-being and health related quality of life (HRQOL). To that effect, this study aims to translate, culturally adapt, and validate the Serbian version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) for patients with vertebral fractures. Methods: Nine female patients with osteoporosis participated in the pre-validation study. A validation, case-control study included two groups of female patients: one that consisted of 50 female patients with osteoporosis, and with at least one vertebral fracture, and another one that consisted of 50 control patients with osteoporosis but without fractures. They completed the QUALEFFO-41 and the EuroQol group questionnaire with five dimensions (EQ-5D) twice within a month. The validation study examined internal consistency, concurrent validity, test-retest reliability, sensitivity and specificity. Results: During the pre-validation study, three of the items in the QUALEFFO-41 were slightly changed. Afterwards, during the validation study, the statistically significant differences (adjusted for: age, duration of menopause, current employment and marital status) in the mean values of all domains and total scores between the groups were noted. For the case group, the internal consistency of the QUALEFFO-41 domains and of total questionnaire was above 0.70. The test-retest reliability was tested by the intraclass correlation coefficients (ICC) that were in range 0.87 - 0.96 for the case, and 0.15 - 0.83 for the control group. Correlations between the total scores of the QUALEFFO-41 and the EQ-5D health state value, for both groups were negative and statistically significant (r = -0.78, p lt 0.001 and r = -0.73, p lt 0.001, respectively). The QUALEFFO-41 had a better prediction of the value of HRQOL of cases compared to the generic questionnaire EQ-5D (the AUC difference was 0.099, p = 0.013). Conclusions: The Serbian QUALEFFO-41 version is reliable, valid, sensitive and predictive for examinations of HRQOL in patients with prevalent vertebral fractures and can be used in further studies. PB - Biomed Central Ltd, London T2 - Health and Quality of Life Outcomes T1 - Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population VL - 10 DO - 10.1186/1477-7525-10-74 ER -
@article{ author = "Tadić, Ivana and Vujasinović-Stupar, Nada and Tasić, Ljiljana and Stevanović, Dejan and Dimić, Aleksandar and Stamenković, Bojana and Stojanović, Sonja and Milenković, Sasa", year = "2012", abstract = "Background: Vertebral fractures could lead to reduced physical, social and mental functioning, and loss of personal independence. Therefore, during the treatment of osteoporosis, it has become necessary to examine the changes in everyday functioning, well-being and health related quality of life (HRQOL). To that effect, this study aims to translate, culturally adapt, and validate the Serbian version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) for patients with vertebral fractures. Methods: Nine female patients with osteoporosis participated in the pre-validation study. A validation, case-control study included two groups of female patients: one that consisted of 50 female patients with osteoporosis, and with at least one vertebral fracture, and another one that consisted of 50 control patients with osteoporosis but without fractures. They completed the QUALEFFO-41 and the EuroQol group questionnaire with five dimensions (EQ-5D) twice within a month. The validation study examined internal consistency, concurrent validity, test-retest reliability, sensitivity and specificity. Results: During the pre-validation study, three of the items in the QUALEFFO-41 were slightly changed. Afterwards, during the validation study, the statistically significant differences (adjusted for: age, duration of menopause, current employment and marital status) in the mean values of all domains and total scores between the groups were noted. For the case group, the internal consistency of the QUALEFFO-41 domains and of total questionnaire was above 0.70. The test-retest reliability was tested by the intraclass correlation coefficients (ICC) that were in range 0.87 - 0.96 for the case, and 0.15 - 0.83 for the control group. Correlations between the total scores of the QUALEFFO-41 and the EQ-5D health state value, for both groups were negative and statistically significant (r = -0.78, p lt 0.001 and r = -0.73, p lt 0.001, respectively). The QUALEFFO-41 had a better prediction of the value of HRQOL of cases compared to the generic questionnaire EQ-5D (the AUC difference was 0.099, p = 0.013). Conclusions: The Serbian QUALEFFO-41 version is reliable, valid, sensitive and predictive for examinations of HRQOL in patients with prevalent vertebral fractures and can be used in further studies.", publisher = "Biomed Central Ltd, London", journal = "Health and Quality of Life Outcomes", title = "Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population", volume = "10", doi = "10.1186/1477-7525-10-74" }
Tadić, I., Vujasinović-Stupar, N., Tasić, L., Stevanović, D., Dimić, A., Stamenković, B., Stojanović, S.,& Milenković, S.. (2012). Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population. in Health and Quality of Life Outcomes Biomed Central Ltd, London., 10. https://doi.org/10.1186/1477-7525-10-74
Tadić I, Vujasinović-Stupar N, Tasić L, Stevanović D, Dimić A, Stamenković B, Stojanović S, Milenković S. Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population. in Health and Quality of Life Outcomes. 2012;10. doi:10.1186/1477-7525-10-74 .
Tadić, Ivana, Vujasinović-Stupar, Nada, Tasić, Ljiljana, Stevanović, Dejan, Dimić, Aleksandar, Stamenković, Bojana, Stojanović, Sonja, Milenković, Sasa, "Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population" in Health and Quality of Life Outcomes, 10 (2012), https://doi.org/10.1186/1477-7525-10-74 . .